Cadre Holdings
Cadre Holdings' revenue rose 7.5% to $610 million in fiscal 2025. Its operating margin was 11.0%, down from 11.8% a year earlier. Free cash flow was $57 million, up 117.7%. It paid out $15 million in dividends and buybacks, 27% of free cash flow. The diluted share count rose 7.7%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
What Cadre Holdings does
Cadre Holdings makes and distributes safety equipment for law enforcement, first responders, the military and the nuclear industry. Its products include body armor, explosive ordnance disposal equipment, duty gear such as holsters, remote handling solutions, containers for radioactive materials, and ventilation and containment systems. Through its own distribution business it also sells third-party items such as uniforms, optics, boots, firearms and ammunition.
Its customers include state, local and international police, fire and rescue departments, bomb disposal technicians, nuclear power plants, emergency medical technicians and corrections departments, plus U.S. federal agencies and foreign governments. It sells through direct and indirect channels. It says it is a top provider of safety holsters and soft body armor for first responders in the U.S.
Cadre says demand comes from technology advances and regular cycles of modernizing and replacing equipment, and that much of its product line is governed by safety standards and regulations. It says it has a large and diverse customer base.
Its biggest risks, as it describes them
- Product liability and warranty claims, because its products protect people in dangerous situations.
- Changes in federal spending that flow through to state and local budgets.
- Customers with changing budgets, which can swing its results.
- Limited sources for some raw materials and components.
- Fixed-price contracts that could lose money, and extensive government regulation.
Income statement
From fiscal 2020 to 2025, earnings per share fell 6.1% a year and net income grew 2.8% a year, as new shares raised the share count by 58% and diluted each share's earnings.
Returns on capital
Balance sheet
Five years at a glance
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | 34 | 45 | 88 | 125 | 123 |
| Debt incl. finance leases | 173 | 152 | 142 | 223 | 310 |
| Net debt (negative means net cash) | 139 | 107 | 55 | 98 | 187 |
| Net debt to EBITDA | 2.1x | 3.3x | 0.8x | 1.2x | 2.2x |
| Debt to equity | 1.9x | 0.9x | 0.7x | 0.7x | 1.0x |
| Interest coverage | 3.1x | 2.7x | 12.5x | 8.5x | 3.8x |
| Current ratio | 2.1x | 2.5x | 2.6x | 3.5x | 3.5x |
| Quick ratio | 1.3x | 1.6x | 1.7x | 2.6x | 2.5x |
Cash flow
Projections
Project Cadre Holdings' revenue, net income and earnings per share five years ahead in a bull, a base and a bear case with your own figures, and see the share prices your P/E estimates give them, or value it with a discounted cash flow model. Every projected figure is yours: it is not a forecast of ours.
What Cadre Holdings says to expect
- Full year 2026: net sales and adjusted EBITDA
Cadre increased its full-year guidance and expects to generate net sales in 2026 of between $756 million and $769 million and Adjusted EBITDA in 2026 of between $140 million and $144 million.
- Full year 2026: capital expenditures
We expect capital expenditures to be in the range of $11 million to $14 million.
Insider trades
Over the 12 months between November 20, 2025 and November 19, 2026, no insider bought Cadre Holdings shares on the open market, and 3 insiders sold $26.3 million.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 25, 2026 | Warren B KandersCEO and Chairman, Director, 10% owner | Sold | 100,000 | $31.87 | $3.2 million | Form 4 |
| Aug 24, 2026 | Warren B KandersCEO and Chairman, Director, 10% owner | Sold | 100,000 | $33.36 | $3.3 million | Form 4 |
| Aug 17, 2026 | Brad WilliamsPresident | Sold | 88,742 | $33.24 | $2.9 million | Form 4 |
| Jun 22, 2026 | Warren B KandersCEO and Chairman, Director, 10% owner | Sold | 50,000 | $27.43 | $1.4 million | Form 4 |
| Jun 18, 2026 | Warren B KandersCEO and Chairman, Director, 10% owner | Sold | 25,000 | $27.86 | $696,500 | Form 4 |
| Jun 17, 2026 | Warren B KandersCEO and Chairman, Director, 10% owner | Sold | 25,000 | $28.68 | $717,000 | Form 4 |
| Jun 16, 2026 | Warren B KandersCEO and Chairman, Director, 10% owner | Sold | 100,000 | $28.19 | $2.8 million | Form 4 |
| Jun 15, 2026 | Warren B KandersCEO and Chairman, Director, 10% owner | Sold | 100,000 | $30.03 | $3.0 million | Form 4 |
| Mar 23, 2026 | Warren B KandersCEO and Chairman, Director, 10% owner | Sold | 100,000 | $31.93 | $3.2 million | Form 4 |
| Mar 20, 2026 | Warren B KandersCEO and Chairman, Director, 10% owner | Sold | 100,000 | $31.40 | $3.1 million | Form 4 |
| Dec 12, 2025 | Blaine BrowersChief Financial Officer | Sold | 20,435 | $43.79 | $894,849 | Form 4 |
| Dec 10, 2025 | Brad WilliamsPresident | Sold | 24,000 | $42.99 | $1.0 million | Form 4 |
Indicators
Four widely used measures, worked out from the company's filings. The cutoffs are the ones their authors or users go by, not a verdict of ours.
| Indicator | FY23 | FY24 | FY25 |
|---|---|---|---|
| Piotroski F-score | 7 of 9 | 4 of 9 | 5 of 9 |
| Rule of 40 | 19.2% | 22.2% | 16.9% |
| Altman Z'' | 3.94 | 4.02 | 3.70 |
| Accruals ratio | −8.4% | 0.8% | −2.8% |
The nine F-score tests
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Pass | Fail | Fail |
| Cash from operations exceeds net income | Pass | Fail | Pass |
| Debt fell relative to assets | Pass | Fail | Fail |
| Current ratio rose | Pass | Pass | Pass |
| Share count didn't rise | Fail | Fail | Fail |
| Gross margin rose | Pass | Fail | Pass |
| Revenue rose relative to assets | Fail | Pass | Fail |
| F-score | 7 of 9 | 4 of 9 | 5 of 9 |
Compare
Put Cadre Holdings side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Cadre Holdings | FY25 | 7.5% | 11.0% | 9.3% | 10.4% | 2.2x | 5 | |
| Rocket Lab | FY25 | 38.0% | −38.0% | −53.5% | −30.2% | — | 6 | Compare |
| National Presto Industries | FY25 | 29.7% | 8.0% | −7.2% | — | — | — | Compare |
| Loar | FY25 | 23.2% | 21.4% | — | 6.1% | 4.0x | 5 | Compare |
| Karman | FY25 | 36.6% | 15.5% | −9.0% | 5.1% | 4.7x | 6 | Compare |
6 years of figures
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | 405 | 427 | 458 | 482 | 568 | 610 |
| Revenue growth | — | 5.6% | 7.2% | 5.4% | 17.6% | 7.5% |
| Gross profit | 153 | 171 | 176 | 201 | 234 | 260 |
| Research and development | 6 | 6 | 7 | 7 | 8 | 11 |
| Operating income | 50 | 52 | 17 | 56 | 67 | 67 |
| Net income | 38 | 13 | 6 | 39 | 36 | 44 |
| Diluted EPS (US$) | 1.40 | 0.44 | 0.16 | 1.02 | 0.90 | 1.02 |
| Diluted shares (millions) | 28 | 29 | 36 | 38 | 40 | 43 |
| Cash flow | ||||||
| Cash from operations | 45 | 40 | 46 | 73 | 32 | 64 |
| Capital expenditure | 5 | 3 | 4 | 7 | 6 | 7 |
| Free cash flow | 41 | 37 | 42 | 66 | 26 | 57 |
| Dividends paid | 0 | 13 | 12 | 12 | 14 | 15 |
| Share buybacks | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | 0 | 0 | 56 | 0 | 142 | 90 |
| Stock-based compensation | — | 0 | 32 | 9 | 8 | 12 |
| Balance sheet at fiscal year end | ||||||
| Cash and short-term investments | 3 | 34 | 45 | 88 | 125 | 123 |
| Debt incl. finance leases | 216 | 173 | 152 | 142 | 223 | 310 |
| Total assets | 283 | 312 | 392 | 431 | 653 | 770 |
| Total liabilities | 274 | 223 | 226 | 234 | 341 | 452 |
| Shareholders' equity | 9 | 89 | 166 | 197 | 312 | 318 |
| Margins and ratios | ||||||
| Gross margin | 37.8% | 40.0% | 38.4% | 41.6% | 41.1% | 42.5% |
| Operating margin | 12.3% | 12.1% | 3.6% | 11.7% | 11.8% | 11.0% |
| Net margin | 9.5% | 3.0% | 1.3% | 8.0% | 6.4% | 7.2% |
| Free cash flow margin | 10.1% | 8.7% | 9.2% | 13.8% | 4.6% | 9.3% |
| Rule of 40 (growth + FCF margin) | — | 14.3% | 16.3% | 19.2% | 22.2% | 16.9% |
| Return on capital | — | 15.2% | 4.2% | 15.7% | 13.4% | 10.4% |
| Return on equity | — | 26.0% | 4.6% | 21.3% | 14.2% | 14.0% |
| Return on assets | — | 4.3% | 1.6% | 9.4% | 6.7% | 6.2% |
| Net debt to EBITDA | 3.3x | 2.1x | 3.3x | 0.8x | 1.2x | 2.2x |